Editing CHO cells with CRISPR-Cas9 improves cell growth and reduces by-products
Researchers have found bioengineering CHO cells using CRISPR-Cas9 can decrease the secretion of metabolic by-products that hinder growth.
List view / Grid view
Researchers have found bioengineering CHO cells using CRISPR-Cas9 can decrease the secretion of metabolic by-products that hinder growth.
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
Scientists in Denmark have made it possible to rank the risk of resistance genes and predict the evolution of existing and future drugs.
We caught up with Andreas Laustsen Co-Founder and CEO of Venomab, to find the latest in antivenom research…